TITLE

Caspase-8, association with Alzheimer’s Disease and functional analysis of rare variants

AUTHOR(S)
Rehker, Jan; Rodhe, Johanna; Nesbitt, Ryan R.; Boyle, Evan A.; Martin, Beth K.; Lord, Jenny; Karaca, Ilker; Naj, Adam; Jessen, Frank; Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko; Ramirez, Alfredo; Scherer, Martin; Farrer, Lindsay A.; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Raskind, Wendy H.; Cruchaga, Carlos; Schellenberg, Gerard D.
PUB. DATE
October 2017
SOURCE
PLoS ONE;10/6/2017, Vol. 12 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The accumulation of amyloid beta (Aβ) peptide (Amyloid cascade hypothesis), an APP protein cleavage product, is a leading hypothesis in the etiology of Alzheimer's disease (AD). In order to identify additional AD risk genes, we performed targeted sequencing and rare variant burden association study for nine candidate genes involved in the amyloid metabolism in 1886 AD cases and 1700 controls. We identified a significant variant burden association for the gene encoding caspase-8, CASP8 (p = 8.6x10-5). For two CASP8 variants, p.K148R and p.I298V, the association remained significant in a combined sample of 10,820 cases and 8,881 controls. For both variants we performed bioinformatics structural, expression and enzymatic activity studies and obtained evidence for loss of function effects. In addition to their role in amyloid processing, caspase-8 and its downstream effector caspase-3 are involved in synaptic plasticity, learning, memory and control of microglia pro-inflammatory activation and associated neurotoxicity, indicating additional mechanisms that might contribute to AD. As caspase inhibition has been proposed as a mechanism for AD treatment, our finding that AD-associated CASP8 variants reduce caspase function calls for caution and is an impetus for further studies on the role of caspases in AD and other neurodegenerative diseases.
ACCESSION #
125540607

 

Related Articles

  • Amyloid β-Protein Assembly as a Therapeutic Target of Alzheimer's Disease. Yamin, Ghiam; Ono, Kenjiro; Inayathullah, Mohammed; Teplow, David B. // Current Pharmaceutical Design;10/21/2008, Vol. 14 Issue 30, p3231 

    Alzheimer's disease (AD), the most common neurodegenerative disorder in the aged, is characterized by the cerebral deposition of fibrils formed by the amyloid β-protein (Aβ), a 40-42 amino acid peptide. The folding of Aβ into neurotoxic oligomeric, protofibrillar, and fibrillar...

  • Interaction of neurons and astrocytes underlies the mechanism of Aβ-induced neurotoxicity. Angelova, Plamena R.; Abramov, Andrey Y. // Biochemical Society Transactions;Oct2014, Vol. 42 Issue 5, p1286 

    Alzheimer's disease (AD) is a neurodegenerative disease characterized by the aggregation of amyloid β-peptide (Aβ) into β-sheet-rich fibrils. Although plaques containing Aβ fibrils have been viewed as the conventional hallmark of AD, recent research implicates small oligomeric...

  • Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration. Woo, J A; Jung, A R; Lakshmana, M K; Bedrossian, A; Lim, Y; Bu, J H; Park, S A; Koo, E H; Mook-Jung, I; Kang, D E // Cell Death & Differentiation;Sep2012, Vol. 19 Issue 9, p1413 

    Neurodegeneration associated with amyloid β (Aβ) peptide accumulation, synaptic loss, neuroinflammation, tauopathy, and memory impairments encompass the pathophysiological features of Alzheimer's disease (AD). We previously reported that the scaffolding protein RanBP9, which is overall...

  • Amyloid-β Decreases Nitric Oxide Production in Cultured Retinal Neurons: A Possible Mechanism for Synaptic Dysfunction in Alzheimer's Disease? Oliveira, Leandro; Louzada, Paulo; Mello, Fernando; Ferreira, Sérgio // Neurochemical Research;Jan2011, Vol. 36 Issue 1, p163 

    The neurotoxicity of the amyloid-β peptide (Aβ) appears to be, at least in part, related to pathological activation of glutamate receptors by Aβ aggregates. However, the downstream signaling pathways leading to neurodegeneration are still incompletely understood. Hyperactivation of...

  • Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer's disease. Kam, Tae-In; Gwon, Youngdae; Jung, Yong-Keun // Cellular & Molecular Life Sciences;Dec2014, Vol. 71 Issue 24, p4803 

    Alzheimer's disease (AD) is the most common neurodegenerative disease. Although a major cause of AD is the accumulation of amyloid-β (Aβ) peptide that induces neuronal loss and cognitive impairments, our understanding of its neurotoxic mechanisms is limited. Recent studies have identified...

  • Novel Aβ Isoforms in Alzheimer's Disease - Their Role in Diagnosis and Treatment. Portelius, Erik; Mattsson, Niklas; Andreasson, Ulf; Blennow, Kaj; Zetterberg, Henrik // Current Pharmaceutical Design;8/21/2011, Vol. 17 Issue 25, p2594 

    The last decades have witnessed an explosion in studies of the role of amyloid-β (Aβ) in the progress of the neurodegenerative disorder Alzheimer's disease (AD) and it is now widely accepted that A is related to the pathogenesis of AD. For example, studies have shown that Aβ is...

  • Aggregation State and Neurotoxic Properties of Alzheimer β-Amyloid Peptide. Mohamed, Amany; Cortez, Leonardo; de Chaves, Elena Posse // Current Protein & Peptide Science;May2011, Vol. 12 Issue 3, p235 

    Alzheimer's disease (AD) represents the most common form of senile dementia and represents a tremendous health problem as the world population is aging. AD is characterized by the accumulation of amyloid -peptide (A) in the brain and the loss of cholinergic neurons in the basal forebrain....

  • Tau oligomers and tau toxicity in neurodegenerative disease. Ward, Sarah M.; Himmelstein, Diana S.; Lancia, Jody K.; Binder, Lester I. // Biochemical Society Transactions;Aug2012, Vol. 40 Issue 4, p667 

    AD (Alzheimer's disease) is a progressive neurodegenerative disorder characterized by the extracellular accumulation of amyloid β-peptide and the intracellular accumulation of tau. Although there is much evidence linking tau to neurodegeneration, the precise mechanism of tau-mediated...

  • Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus. Ali, Tahir; Yoon, Gwang Ho; Shah, Shahid Ali; Lee, Hae Young; Kim, Myeong Ok // Scientific Reports;7/3/2015, p11708 

    The pathological hallmarks of Alzheimer's disease (AD) include amyloid beta (Aβ) accumulation, neurofibrillary tangle formation, synaptic dysfunction and neuronal loss. In this study, we investigated the neuroprotection of novel osmotin, a plant protein extracted from Nicotiana tabacum that...

  • Effect of Alanine Replacement of L17 and F19 on the Aggregation and Neurotoxicity of Arctic-Type Aβ40. Chen, Yi-Ru; Huang, Hsien-bin; Lo, Chi-Jen; Wang, Chih-Ching; Ho, Li-Kang; Liu, Hsin-Tzu; Shiao, Ming-Shi; Lin, Ta-Hsien; Chen, Yi-Cheng // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Alzheimer’s disease is the most common form of neurodegenerative disease. Beta-amyloid peptides (Aβ) are responsible for neuronal death both in vitro and in vivo. Previously, L17 and F19 residues were identified as playing key roles in the stabilization of the Aβ40 conformation and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics